Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-07

Clinical Trial Update: Dysport® Adult Upper Limb Spasticity Extension Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial extension study for Dysport in adult upper limb spasticity has completed; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Ipsen | Conditions: Nervous System Disorders | Phase 3 | Status: COMPLETED | Results posted: 2017-06-07